A DOTAM-based paraCEST agent favoring TSAP geometry for enhanced amide proton chemical shift dispersion and temperature sensitivity

Contrast Media and Molecular Imaging

Volumn 8, Issue 3, 2013, Pages 289-292

  Stevens, Todd K ^a   Milne, Mark ^b   Elmehriki, Adam A H ^b   Suchý, Mojmír ^a,b   Bartha, Robert ^a   Hudson, Robert H E ^b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

MRI; PARACEST; SAP; T butyl amide; Temperature; Thulium; TSAP

Indexed keywords

1,4,7,10 TETRAKIS(CARBAMOYLMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE; AMIDE; CHELATE; DODECANE; PROTON; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; GEOMETRY; HIGH TEMPERATURE; MACROMOLECULE; PARAMAGNETIC CHEMICAL EXCHANGE SATURATION TRANSFER; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE SENSITIVITY; TWISTED SQUARE ANTIPRISMATIC GEOMETRY;

ACETAMIDES; AMIDES; CONTRAST MEDIA; HETEROCYCLIC COMPOUNDS, 1-RING; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 84875788335     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1527     Document Type: Article

References (23)

1. Zhou J, van Zijl PCM. Chemical exchange saturation transfer imaging and spectroscopy. Prog Nucl Magn Reson Spectrosc 2006; 48: 109-136.
2. Pacheco-Torres J, Calle D, Lizarbe B, Negri V, Ubide C, Fayos R, Larrubia PL, Ballesteros P, Cerdan S. Environmentally sensitive paramagnetic and diamagnetic contrast agents for nuclear magnetic resonance imaging and spectroscopy. Curr Top Med Chem 2011; 11(1): 115-130.
3. Li AX, Hudson RHE, Barrett JW, Jones CK, Pasternak SH, Bartha R. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents. Magn Reson Med 2008; 60(5): 1197-1206.
4. Aime S, Barge A, Bruce JI, Botta M, Howard JAK, Moloney JM, Parker D, de Sousa AS, Woods M. NMR, relaxometric, and structural studies of the hydration and exchange dynamics of cationic lanthanide complexes of macrocyclic tetraamide ligands. J Am Chem Soc 1999; 121(24): 5762-5771.
5. Aime S, Barge A, Botta M, De Sousa AS, Parker D. Direct NMR spectroscopic observation of a lanthanide-coordinated water molecule whose exchange rate is dependent on the conformation of the complexes. Angew Chem Int Ed Engl 1998; 37(19): 2673-2675.
6. Miller KJ, Saherwala AA, Webber BC, Wu Y, Sherry AD, Woods M. The population of SAP and TSAP isomers in cyclen-based lanthanide(III) chelates is substantially affected by solvent. Inorg Chem 2010; 49(19): 8662-8664.
7. Zhang SR, Merritt M, Woessner DE, Lenkinski RE, Sherry AD. PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res 2003; 36(10): 783-790.
8. Yoo B, Pagel MD. Peptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach. Bioconjug Chem 2007; 18(3): 903-911.
9. Yoo B, Pagel MD. A PARACEST MRI contrast agent to detect enzyme activity. J Am Chem Soc 2006; 128(43): 14032-14033.
10. Li Y, Sheth VR, Liu G, Pagel MD. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Eur J Nucl Med Mol Imaging 2011; 6(4): 219-228.
11. 3+ DOTAM-Gly-Lys-OH: synthesis and magnetic properties of potential PARACEST MRI contrast agents. Bioorg Med Chem 2008; 16(11): 6156-6166.
12. Milne M, Chicas K, Li A, Bartha R, Hudson RHE. ParaCEST MRI contrast agents capable of derivatization via 'click' chemistry. Org Biomol Chem 2012; 10: 287-292.
13. Woods M, Caravan P, Geraldes CFGC, Greenfield MT, Kiefer GE, Lin M, McMillan K, Prata MIM, Santos AC, Sun X, Wang J, Zhang S, Zhao P, Sherry AD. The effect of the amide substituent on the biodistribution and tolerance of lanthanide(III) DOTA-tetraamide derivatives. Invest Radiol 2008; 43(12): 861-870.
14. Pikkemaat JA, Wegh RT, Lamerichs R, van de Molengraaf RA, Langereis S, Burdinski D, Raymond AYF, Janssen HM, de Waal BFM, Willard NP, Meijer EW, Grull H. Dendritic PARACEST contrast agents for magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2007; 2(5): 229-239.
15. Chauvin T, Durand P, Bernier M, Meudal H, Doan BT, Noury F, Badet B, Beloeil JC, Toth E. Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Angew Chem Int Ed Engl 2008; 47(23): 4370-4372.
16. Viswanathan S, Kovacs Z, Green KN, Ratnakar SJ, Sherry AD. Alternatives to gadolinium-based metal chelates for magnetic resonance imaging. Chem Rev 2010; 110(5): 2960-3018.
17. Mani T, Tircso G, Togao O, Zhao P, Soesbe TC, Takahashi M, Sherry AD. Modulation of water exchange in Eu(III) DOTA-tetraamide complexes: considerations for in vivo imaging of PARACEST agents. Eur J Nucl Med Mol Imaging 2009; 4: 183-191.
18. Mani T, Tircsó G, Zhao P, Sherry AD, Woods M. Effect of the regiochemistry of butyl amide substituents on the solution-state structures of lanthanide(III) DOTA-tetraamide complexes. Inorg Chem 2009; 48(21): 10338-10345.
19. DelliCastelli D, Terreno E, Aime S. YbIII-HPDO3A: a dual pH- and temperature-responsive CEST agent. Angew Chem Int Ed Engl 2011; 50(8): 1798-1800.
20. Wojciechowski F, Suchy M, Li AX, Azab HA, Bartha R, Hudson RHE. A robust and convergent synthesis of Dipeptide-DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents. Bioconjug Chem 2007; 18(5): 1625-1636.
21. McConnell HM. Reaction rates by nuclear magnetic resonance. J Chem Phys 1958; 28(3): 430-431.
22. Dorazio SJ, Tsitovich PB, Siters KE, Spernyak JA, Morrow JR. Iron(II) PARACEST MRI contrast agents. J Am Chem Soc 2011; 133(36): 14154-14156.
23. Sherry AD, Zhang S, Wu K. PCT Int. Appl, WO 2002043775 A2 20020606, 2002.